HK1250515A1 - 使用lgr4，lgr5和lgr6在組織應用中開發和使用最小極化功能細胞微集合體單元的方法 - Google Patents

使用lgr4，lgr5和lgr6在組織應用中開發和使用最小極化功能細胞微集合體單元的方法

Info

Publication number
HK1250515A1
HK1250515A1 HK18104680.7A HK18104680A HK1250515A1 HK 1250515 A1 HK1250515 A1 HK 1250515A1 HK 18104680 A HK18104680 A HK 18104680A HK 1250515 A1 HK1250515 A1 HK 1250515A1
Authority
HK
Hong Kong
Prior art keywords
lgr4
lgr6
lgr5
development
methods
Prior art date
Application number
HK18104680.7A
Other languages
English (en)
Inventor
M Lough Denver
Original Assignee
Polarityte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56078499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1250515(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polarityte Inc filed Critical Polarityte Inc
Publication of HK1250515A1 publication Critical patent/HK1250515A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Developmental Biology & Embryology (AREA)
HK18104680.7A 2014-12-02 2018-04-10 使用lgr4，lgr5和lgr6在組織應用中開發和使用最小極化功能細胞微集合體單元的方法 HK1250515A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462086526P 2014-12-02 2014-12-02
US14/954,335 US10926001B2 (en) 2014-12-02 2015-11-30 Methods related to minimally polarized functional units
PCT/US2015/063114 WO2016089825A1 (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells

Publications (1)

Publication Number Publication Date
HK1250515A1 true HK1250515A1 (zh) 2018-12-21

Family

ID=56078499

Family Applications (2)

Application Number Title Priority Date Filing Date
HK18104680.7A HK1250515A1 (zh) 2014-12-02 2018-04-10 使用lgr4，lgr5和lgr6在組織應用中開發和使用最小極化功能細胞微集合體單元的方法
HK18104679.0A HK1245327A1 (zh) 2014-12-02 2018-04-10 使用表達lgr4、lgr5和lgr6的上皮幹細胞在組織應用中開發和使用最小極性化功能細胞微聚集體單元的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18104679.0A HK1245327A1 (zh) 2014-12-02 2018-04-10 使用表達lgr4、lgr5和lgr6的上皮幹細胞在組織應用中開發和使用最小極性化功能細胞微聚集體單元的方法

Country Status (21)

Country Link
US (7) US10926001B2 (zh)
EP (1) EP3227431A4 (zh)
JP (3) JP6791854B2 (zh)
KR (5) KR20170098844A (zh)
CN (1) CN107250348B (zh)
AU (3) AU2015355187C1 (zh)
BR (1) BR112017011808A2 (zh)
CA (1) CA2969707C (zh)
CO (1) CO2017006640A2 (zh)
CR (1) CR20170296A (zh)
EA (1) EA201791125A1 (zh)
GB (2) GB2549872A (zh)
HK (2) HK1250515A1 (zh)
IL (2) IL252613B (zh)
MX (2) MX2017007243A (zh)
MY (1) MY184931A (zh)
NZ (2) NZ755260A (zh)
PH (1) PH12017501009B1 (zh)
SG (2) SG10201914058QA (zh)
WO (1) WO2016089825A1 (zh)
ZA (1) ZA201703907B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3743125A4 (en) * 2018-01-26 2022-03-02 Polarityte, Inc. BIOMATERIAL ACCELERATING SUBSTRATE WITH COMPOSITE INTERFACE
AU2019212976A1 (en) * 2018-01-26 2020-07-23 Polarityte, Inc. Complex living interface-coordinated self-assembling materials (CLICSAM)
FR3082123B1 (fr) 2018-06-07 2020-10-16 Urgo Rech Innovation Et Developpement Pansement cellularise et son procede de fabrication

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126881A1 (en) * 2002-09-06 2004-07-01 Vincent Ronfard Fibrin cell supports and methods of use thereof
WO2006008009A2 (en) 2004-07-23 2006-01-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with leucine-rich repeat-containing gpcr 6 (lgr6)
WO2006026617A2 (en) 2004-08-30 2006-03-09 Iken Tissue Therapeutics, Inc. Compositions and methods of promoting hair growth
WO2007048831A2 (en) * 2005-10-27 2007-05-03 Coloplast A/S Biodegradable scaffold with ecm material
WO2008008009A1 (en) 2006-07-13 2008-01-17 St. Jude Medical Ab Medical information management in a patient information hub system
US8366723B2 (en) 2006-08-03 2013-02-05 Rassman Licensing, Llc Hair harvesting device and method with localized subsurface dermal fluid insertion
EP2066787A1 (en) 2006-09-12 2009-06-10 DKFZ Deutsches Krebsforschungszentrum, Stiftung des Öffentlichen Rechts Cell culture of keratinocytes under non-differentiating conditions
GB201111244D0 (en) 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
FI20095355A0 (fi) 2009-04-01 2009-04-01 Helsingin Yliopisto Regeneroituva aktiivinen matriisi ja sen käytöt
TW201110973A (en) 2009-06-25 2011-04-01 Shiseido Co Ltd Methods for screening for anti-graying agents on the basis of AFF-4
US20110130711A1 (en) 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
KR20130041103A (ko) 2010-06-30 2013-04-24 진시 첸 피부조직세포 응집체의 제조방법과 및 그 용도
GB201106395D0 (en) 2011-04-14 2011-06-01 Hubrecht Inst Compounds
AU2012328353B2 (en) 2011-10-27 2017-05-25 Universitat Leipzig Method for deriving melanocytes from the hair follicle outer root sheath and preparation for grafting
JP6186997B2 (ja) 2012-08-07 2017-08-30 日油株式会社 塗布型帯電防止剤
US9655930B2 (en) 2012-10-01 2017-05-23 Aderans Research Institute, Inc. Compositions and methods for producing reconstituted skin
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
HUE049377T2 (hu) 2013-03-14 2020-09-28 Brigham & Womens Hospital Inc Készítmények és eljárások epiteliális õssejtek expanziójára és tenyésztésére
US9592257B2 (en) 2013-10-11 2017-03-14 MWV Cell, LLC Complete human skin organ generated from culture-expanded cells
CN103550828B (zh) * 2013-10-17 2016-01-27 中国科学院动物研究所 一种基于毛囊干细胞和硅凝胶敷料的皮肤重建方法
TWI548413B (zh) 2014-11-07 2016-09-11 國立臺灣大學 誘導毛囊新生的皮膚萃取物、組合物及其用途

Also Published As

Publication number Publication date
US11596714B2 (en) 2023-03-07
GB201902819D0 (en) 2019-04-17
MX2017007243A (es) 2018-01-25
AU2019240603A1 (en) 2019-10-17
US11266765B2 (en) 2022-03-08
EA201791125A1 (ru) 2018-06-29
NZ755260A (en) 2021-12-24
PH12017501009A1 (en) 2017-12-11
CO2017006640A2 (es) 2017-11-21
AU2015355187A1 (en) 2017-06-29
CN107250348B (zh) 2021-09-03
US11000629B2 (en) 2021-05-11
CN107250348A (zh) 2017-10-13
GB2549872A (en) 2017-11-01
AU2015355187C1 (en) 2020-02-20
NZ733433A (en) 2019-08-30
GB2569056A (en) 2019-06-05
US20190046691A1 (en) 2019-02-14
PH12017501009B1 (en) 2017-12-11
AU2023202857A1 (en) 2023-05-25
BR112017011808A2 (pt) 2018-02-27
CR20170296A (es) 2018-01-25
US20230181797A1 (en) 2023-06-15
KR20190111167A (ko) 2019-10-01
JP2017538411A (ja) 2017-12-28
US20160151540A1 (en) 2016-06-02
GB2569056B (en) 2020-01-01
IL287488A (en) 2021-12-01
JP2020182880A (ja) 2020-11-12
KR20210043024A (ko) 2021-04-20
KR20180136587A (ko) 2018-12-24
US20220241464A1 (en) 2022-08-04
US20210322643A1 (en) 2021-10-21
US20180154044A1 (en) 2018-06-07
ZA201703907B (en) 2023-03-29
KR20170098844A (ko) 2017-08-30
SG10201914058QA (en) 2020-03-30
KR20180136588A (ko) 2018-12-24
WO2016089825A1 (en) 2016-06-09
MY184931A (en) 2021-04-30
EP3227431A4 (en) 2019-01-02
AU2015355187B2 (en) 2019-10-03
US10926001B2 (en) 2021-02-23
HK1245327A1 (zh) 2018-08-24
EP3227431A1 (en) 2017-10-11
CA2969707A1 (en) 2016-06-09
US11338060B2 (en) 2022-05-24
CA2969707C (en) 2019-08-20
JP2019088299A (ja) 2019-06-13
IL287488B2 (en) 2023-06-01
IL252613A0 (en) 2017-07-31
SG11201704502RA (en) 2017-06-29
IL252613B (en) 2021-12-01
AU2019240603B2 (en) 2023-02-09
MX2023001655A (es) 2023-04-24
GB201710646D0 (en) 2017-08-16
JP6791854B2 (ja) 2020-11-25
US20180154043A1 (en) 2018-06-07

Similar Documents

Publication Publication Date Title
HK1223628A1 (zh) β- 新的 -酮- β-烷基膽烷酸衍生物在製備奧貝膽酸以及其在醫藥領域的用途
HRP20180631T1 (hr) Analog mini-gastrina, posebno u uporabi za dijagnozu i/ili liječenje tumora pozitivnog na receptor cck2
IL287488A (en) Methods for the development and use of minimally polarized microaggregate cell units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
EP3091603A4 (en) Electrolytic solution and electrochemical device
HK1222562A1 (zh) 用於醫學診斷的組合物及方法
SG11201704423SA (en) Aminoacid-based composition for fibroelastin recovery in dermal connective tissues
EP3215157B8 (en) Apilimod for use in the treatment of melanoma
EP3168916A4 (en) Electrolytic solution and electrochemical device
IL248855A0 (en) S-pyralindole and its pharmaceutically acceptable salts for use in medicine
SG11201605772YA (en) Use of phospho-tartaric acid and the salts therof for the treatment of water in water-conducting systems
WO2014146111A3 (en) Analgesic compounds and methods of use
GB2525493B (en) Improvements in or relating to medical and veterinarian rotary tools
HK1220135A1 (zh) 胎盤幹細胞治療急性腎損傷的用途
EP3133623A4 (en) Solvent for electrolytic solution for use in electrochemical devices
DK3145548T3 (en) Aqueous gel composition and its use
TH1601006738A (th) (s)-เพอร์ลินโดล และเกลือที่ยอมรับได้ทางเภสัชกรรมของมันสำหรับ การใช้ในยารักษาโรค
ZA201404780B (en) Composition for use in treatment of diabetes
AU2014902487A0 (en) An apparatus for use in energy generation and/or energy storage
GB201404668D0 (en) Improvements in or relating to medical and veterinarian rotary tools